Mast Therapeutics Company Profile (NYSEMKT:MSTX)

About Mast Therapeutics

Mast Therapeutics logoMast Therapeutics, Inc. is a biopharmaceutical company. The Company develops clinical-stage therapies for serious or life-threatening diseases with unmet needs. The Company focuses on developing new therapies for sickle cell disease, a chronic and genetic disorder classified as a rare, or orphan, disease in the United States of America and European Union, and for heart failure, a condition with an unmet need for treatment options. The Company's segment is engaged in the business of developing therapies for serious or life-threatening diseases. The Company focuses on its Molecular Adhesion and Sealant Technology (MAST) platform, to develop MST-188 (vepoloxamer) Injection, its lead product candidate. The Company also develops AIR001, a sodium nitrite solution for intermittent inhalation through nebulizer. The Company's AIR001 is in Phase II clinical development for the treatment of patients with HFpEF.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NYSEMKT
  • Symbol: MSTX
  • CUSIP:
Key Metrics:
  • Previous Close: $0.43
  • 50 Day Moving Average: $0.3956
  • 200 Day Moving Average: $0.3478
  • 52-Week Range: $0.21 - $0.60
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 8.58
  • P/E Growth: 0.0000
  • Market Cap: $90.89M
  • Outstanding Shares: 211,815,000
  • Beta: 1.16
Additional Links:
Companies Related to Mast Therapeutics:

Analyst Ratings

Consensus Ratings for Mast Therapeutics (NYSEMKT:MSTX) (?)
Ratings Breakdown: 4 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $3.67

Analysts' Ratings History for Mast Therapeutics (NYSEMKT:MSTX)
Show:
DateFirmActionRatingPrice TargetDetails
5/25/2016Maxim GroupReiterated RatingBuy$5.00View Rating Details
2/2/2016Canaccord GenuityReiterated RatingBuy$3.00View Rating Details
10/12/2015Cowen and CompanyReiterated RatingBuyView Rating Details
10/8/2015Roth CapitalReiterated RatingBuy$3.00View Rating Details
9/16/2014Piper Jaffray Cos.Reiterated RatingOverweight$1.00 -> $1.20View Rating Details
9/8/2014LaidlawReiterated RatingBuyView Rating Details
(Data available from 8/30/2014 forward)

Earnings

Earnings History for Mast Therapeutics (NYSEMKT:MSTX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/6/2016Q116($0.06)($0.06)ViewN/AView Earnings Details
3/14/2016Q415($0.06)($0.06)ViewN/AView Earnings Details
11/12/2015Q315($0.06)($0.06)ViewListenView Earnings Details
8/12/2015($0.04)($0.06)ViewN/AView Earnings Details
8/12/2015Q215($0.04)($0.06)ViewListenView Earnings Details
5/11/2015Q1($0.06)($0.06)ViewN/AView Earnings Details
3/24/2015Q414($0.06)($0.05)ViewN/AView Earnings Details
10/31/2014Q314($0.06)($0.06)ViewN/AView Earnings Details
8/11/2014Q214($0.06)($0.06)ViewN/AView Earnings Details
5/5/2014Q114($0.07)($0.06)ViewN/AView Earnings Details
3/26/2014($0.07)($0.06)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Mast Therapeutics (NYSEMKT:MSTX)
Current Year EPS Consensus Estimate: $-0.2100 EPS
Next Year EPS Consensus Estimate: $0.0500 EPS

Dividends

Dividend History for Mast Therapeutics (NYSEMKT:MSTX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Mast Therapeutics (NYSEMKT:MSTX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/27/2015Brandi RobertsCFOBuy38,000$0.50$19,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Mast Therapeutics (NYSEMKT:MSTX)
DateHeadline
News IconHC Trending Hot Stocks: Bristol-Myers Squibb Co (BMY), Mast Therapeutics Inc (MSTX) - share market updates (press release) (NYSEMKT:MSTX)
sharemarketupdates.com - August 25 at 11:25 AM
News IconBiotech news that matter for investors: Mast Therapeutics, Inc. (NYSEMKT:MSTX), Intrexon Corporation (NYSE:XON) - The Voice Registrar (NYSEMKT:MSTX)
voiceregistrar.com - August 23 at 6:29 PM
istreetwire.com logoStocks Roundup: ONEOK Inc. (OKE), Mast Therapeutics, Inc. (MSTX), The Wendy's Company (WEN) - iStreetWire (NYSEMKT:MSTX)
istreetwire.com - August 23 at 10:43 AM
News IconMSTX April 2017 Options Begin Trading (NYSEMKT:MSTX)
www.stockoptionschannel.com - August 22 at 6:18 PM
finance.yahoo.com logoMAST THERAPEUTICS, INC. Financials (NYSEMKT:MSTX)
finance.yahoo.com - August 19 at 6:13 PM
News IconBiotechnology Stocks in Limelight: Novavax, Inc. (NASDAQ:NVAX), Mast Therapeutics Inc (NYSEMKT:MSTX) - Post Registrar (NYSEMKT:MSTX)
postregistrar.com - August 16 at 6:26 PM
News IconMix Momentum Detain Active Stocks- Mast Therapeutics (NYSE ... - Seneca Globe (NYSEMKT:MSTX)
www.senecaglobe.com - August 10 at 6:43 PM
News IconNews review of 2 biotech stocks: Mast Therapeutics, Inc. (NYSEMKT:MSTX), Clovis Oncology, Inc. (NASDAQ:CLVS) - The Voice Registrar (NYSEMKT:MSTX)
voiceregistrar.com - August 10 at 6:43 PM
News IconHC Stocks Updates: UnitedHealth Group Inc (UNH), Mast Therapeutics Inc (MSTX) - share market updates (press release) (NYSEMKT:MSTX)
sharemarketupdates.com - August 10 at 6:43 PM
News IconTrading the Biotech News: Mast Therapeutics, Inc. (NYSEMKT:MSTX), Amicus Therapeutics, Inc. (NASDAQ:FOLD) - The Voice Registrar (NYSEMKT:MSTX)
voiceregistrar.com - August 9 at 6:33 PM
streetupdates.com logoAnalyst Rating Trends to Observe: Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) , Mast Therapeutics, Inc ... - Street Updates (NYSEMKT:MSTX)
www.streetupdates.com - August 9 at 9:28 AM
publicnow.com logoMast Therapeutics Awarded Small Business Innovation Research Grant From The National Institutes Of Health (NYSEMKT:MSTX)
www.publicnow.com - August 8 at 10:58 AM
finance.yahoo.com logo8:09 am Mast Therapeutics receives a Small Business Innovation Research grant from the NIH (NYSEMKT:MSTX)
finance.yahoo.com - August 8 at 10:58 AM
News IconAnalyst Stock Ratings: Mast Therapeutics, Inc. (NYSEMKT:MSTX), Enbridge Energy Partners, L.P. (NYSE:EEP) - TWN (NYSEMKT:MSTX)
thewellesleysnews.com - August 6 at 9:08 AM
News IconWorth Watching Stock's Buzzers: Mast Therapeutics Inc (NYSEMKT:MSTX), Cummins Inc.(NYSE:CMI) - NYSE Journal (press release) (NYSEMKT:MSTX)
stockznews.com - August 4 at 6:41 PM
smarteranalyst.com logoRoth Capital Bullish on Mast Therapeutics Inc (MSTX) Following Successful Phase II Results for AIR001 - Smarter Analyst (NYSEMKT:MSTX)
www.smarteranalyst.com - August 4 at 9:29 AM
News IconMast Therapeutics Inc (NYSEMKT:MSTX): Here's What We're ... - Insider Financial (NYSEMKT:MSTX)
www.insiderfinancial.com - August 4 at 9:28 AM
smarteranalyst.com logoMaxim Analyst Weighs in on Mast Therapeutics Inc (MSTX) Following Phase II Update for AIR001 - Smarter Analyst (NYSEMKT:MSTX)
www.smarteranalyst.com - August 3 at 9:37 AM
smarteranalyst.com logoRoth Capital Bullish on Mast Therapeutics Inc (MSTX) Following ... - Smarter Analyst (NYSEMKT:MSTX)
www.smarteranalyst.com - August 3 at 9:37 AM
publicnow.com logoMast Therapeutics Announces Issuance Of Composition Of Matter Patent Covering Vepoloxamer (NYSEMKT:MSTX)
www.publicnow.com - August 3 at 9:37 AM
finance.yahoo.com logoMast Therapeutics To Present At 36th Annual Canaccord Genuity Growth Conference On August 10 (NYSEMKT:MSTX)
finance.yahoo.com - August 2 at 11:07 AM
fortune.com logoNotable Analyst Views: Halcon Resources Corp (NYSE:HK), Mast ... - Review Fortune (NYSEMKT:MSTX)
reviewfortune.com - August 1 at 6:04 PM
News IconHC Stocks Judgment: Mast Therapeutics Inc (NYSEMKT:MSTX) Brookdale Senior Living, Inc. (NYSE:BKD) - share market updates (press release) (NYSEMKT:MSTX)
sharemarketupdates.com - August 1 at 6:04 PM
smarteranalyst.com logoCompany Update (NYSEMKT:MSTX): Mast Therapeutics Inc Announces Initiation Of Phase 2 Study Of AIR001 ... - Smarter Analyst (NYSEMKT:MSTX)
www.smarteranalyst.com - August 1 at 6:04 PM
smarteranalyst.com logoRoth Capital Remains Bullish on Mast Therapeutics Inc (MSTX); Says Market Overreacting to Brief Delay in EPIC Top ... - Smarter Analyst (NYSEMKT:MSTX)
www.smarteranalyst.com - July 30 at 9:08 AM
streetupdates.com logoLatest Analysts Score of Stocks: Mast Therapeutics, Inc. (NYSEMKT ... - Street Updates (NYSEMKT:MSTX)
www.streetupdates.com - July 27 at 6:36 PM
smarteranalyst.com logoMaxim Weighs in on Mast Therapeutics Inc (MSTX) Following Delay ... - Smarter Analyst (NYSEMKT:MSTX)
www.smarteranalyst.com - July 27 at 6:36 PM
streetinsider.com logoMast Therapeutics (MSTX) Enters Amended Loan Agreement; Updates on EPIC Study TIming - StreetInsider.com (NYSEMKT:MSTX)
www.streetinsider.com - July 26 at 6:36 PM
smarteranalyst.com logoCanaccord Weighs in on Mast Therapeutics Inc (MSTX) as it Delays Results From Phase 3 Clinical Study of Vepoloxamer - Smarter Analyst (NYSEMKT:MSTX)
www.smarteranalyst.com - July 26 at 6:36 PM
News IconBiotechnology Stocks Under Investors' Scanner -- Mast Therapeutics, ZIOPHARM Oncology, Amicus Therapeutics, and Repros Therapeutics (NYSEMKT:MSTX)
www.kait8.com - July 26 at 9:33 AM
streetinsider.com logoMast Therapeutics (MSTX) Enters Amended Loan Agreement; Updates on EPIC Study TIming (NYSEMKT:MSTX)
www.streetinsider.com - July 26 at 9:33 AM
biz.yahoo.com logoMAST THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of Operations and Fin (NYSEMKT:MSTX)
biz.yahoo.com - July 25 at 5:03 PM
4-traders.com logoTobira Therapeutics Inc : Biotech Firms Fighting Cancer (NYSEMKT:MSTX)
www.4-traders.com - July 25 at 10:48 AM
News IconHC Stocks Watchful: UnitedHealth Group Inc (NYSE:UNH), Mast Therapeutics Inc (NYSEMKT:MSTX) - share market updates (press release) (NYSEMKT:MSTX)
sharemarketupdates.com - July 20 at 7:01 PM
streetupdates.com logoAnalysts Rating Overview: AbbVie Inc. (NYSE:ABBV) , Mast Therapeutics, Inc. (NYSEMKT:MSTX) - Street Updates (NYSEMKT:MSTX)
www.streetupdates.com - July 20 at 7:01 PM
streetupdates.com logoUpdated Analysts Rating Report: Mast Therapeutics, Inc. (NYSEMKT:MSTX) , Mallinckrodt plc (NYSE:MNK) - Street Updates (NYSEMKT:MSTX)
www.streetupdates.com - July 19 at 10:43 AM
News Icon2 Biotech Stocks News And Price Trends: Mast Therapeutics, Inc. (NYSEMKT:MSTX), Northwest Biotherapeutics, Inc ... - The Voice Registrar (NYSEMKT:MSTX)
voiceregistrar.com - July 19 at 10:43 AM
streetupdates.com logoKeep an eye on Analyst Actions: Ionis Pharmaceuticals Inc (NASDAQ:IONS) , Mast Therapeutics, Inc. (NYSEMKT:MSTX) - Street Updates (NYSEMKT:MSTX)
www.streetupdates.com - July 18 at 11:36 AM
News IconShares Moving Down on the Week: Mast Therapeutics, Inc. (:MSTX) - Engelwood Daily (NYSEMKT:MSTX)
www.engelwooddaily.com - July 17 at 10:35 AM
News IconShares Experiencing a Downtrend: Mast Therapeutics, Inc. (:MSTX) - TGP (NYSEMKT:MSTX)
telanaganapress.com - July 17 at 10:35 AM
smarteranalyst.com logoRoth Capital Provides Scenario Analysis of Mast Therapeutics Inc (MSTX) EPIC Trial - Smarter Analyst (NYSEMKT:MSTX)
www.smarteranalyst.com - July 15 at 5:21 PM
istreetwire.com logoStocks in the Spotlight: Cabot Oil & Gas Corporation (COG), Mast Therapeutics, Inc. (MSTX), Gentex Corp. (GNTX) - iStreetWire (NYSEMKT:MSTX)
istreetwire.com - July 15 at 10:53 AM
streetupdates.com logoAnalysts Suggestion Alert: CytRx Corporation (NASDAQ:CYTR) , Mast Therapeutics, Inc. (NYSEMKT:MSTX) - Street Updates (NYSEMKT:MSTX)
www.streetupdates.com - July 15 at 10:53 AM
tradecalls.org logoCompany Shares of Mast Therapeutics (NYSEMKT:MSTX) Rally 8.78% - Trade Calls (NYSEMKT:MSTX)
www.tradecalls.org - July 12 at 6:35 PM
streetupdates.com logoAnalysts Observing Stocks Update: BioLife Solutions, Inc. (NASDAQ:BLFS) , Mast Therapeutics, Inc. (NYSEMKT:MSTX) - Street Updates (NYSEMKT:MSTX)
www.streetupdates.com - July 12 at 6:35 PM
News IconMast Therapeutics Incorporated (NYSEMKT:MSTX) Shorted Shares Increased 39.32% After Market Selling - Consumer Eagle (NYSEMKT:MSTX)
www.consumereagle.com - July 11 at 6:19 PM
tradecalls.org logoMast Therapeutics (MSTX) : Analyst Rating Update - Trade Calls (NYSEMKT:MSTX)
www.tradecalls.org - July 7 at 9:10 AM
streetupdates.com logoRecent Analysts Ratings Fluctuations: Galena Biopharma, Inc. (NASDAQ:GALE) , Mast Therapeutics, Inc. (NYSEMKT ... - Street Updates (NYSEMKT:MSTX)
www.streetupdates.com - July 6 at 6:30 PM
streetupdates.com logoTraders Focused Stocks: Eleven Biotherapeutics, Inc. (NASDAQ:EBIO) , Mast Therapeutics, Inc. (NYSEMKT:MSTX) - Street Updates (NYSEMKT:MSTX)
www.streetupdates.com - July 6 at 6:30 PM
News IconStock in the Spotlight: Mast Therapeutics, Inc. (NYSEMKT:MSTX) - News Oracle (NYSEMKT:MSTX)
www.newsoracle.com - July 6 at 6:30 PM

Social


Last Updated on 8/30/2016 by MarketBeat.com Staff